Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.855 CAD | +0.65% | +7.82% | +0.26% |
Sales 2024 * | 969M 708M | Sales 2025 * | 1.06B 777M | Capitalization | 941M 688M |
---|---|---|---|---|---|
Net income 2024 * | 1M 731K | Net income 2025 * | 15M 10.96M | EV / Sales 2024 * | 1.25 x |
Net Debt 2024 * | 273M 200M | Net Debt 2025 * | 243M 178M | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
255
x | P/E ratio 2025 * |
-
| Employees | 1,507 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.1% |
Latest transcript on WELL Health Technologies Corp.
1 day | -2.30% | ||
1 week | +4.93% | ||
Current month | +4.93% | ||
1 month | +5.80% | ||
3 months | +0.52% | ||
6 months | -11.34% | ||
Current year | -0.52% |
Managers | Title | Age | Since |
---|---|---|---|
Hamed Shahbazi
CEO | Chief Executive Officer | 49 | 10-11-22 |
Eva Fong
DFI | Director of Finance/CFO | - | - |
Brian Levinkind
DFI | Director of Finance/CFO | 59 | 10-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Liston
BRD | Director/Board Member | 50 | 18-04-29 |
Ken Cawkell
BRD | Director/Board Member | 72 | 16-03-23 |
Hamed Shahbazi
CEO | Chief Executive Officer | 49 | 10-11-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 1 M€ | -.--% | - | |
0.03% | 146 M€ | -2.58% | - | |
0.02% | 29 M€ | -2.30% | - | |
0.02% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 3.855 | +0.65% | 430 412 |
24-05-13 | 3.83 | -2.30% | 855,799 |
24-05-10 | 3.92 | -2.73% | 1,223,054 |
24-05-09 | 4.03 | +1.77% | 2,377,972 |
24-05-08 | 3.96 | +10.61% | 4,519,729 |
Delayed Quote Toronto S.E., May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.52% | 688M | |
+17.18% | 83.07B | |
-28.48% | 70.89B | |
+5.28% | 28.32B | |
-7.44% | 17.73B | |
+2.07% | 17.43B | |
+2.10% | 15.64B | |
+7.02% | 13.46B | |
+64.96% | 12.69B | |
+6.93% | 12.82B |
- Stock Market
- Equities
- WELL Stock